Status:
RECRUITING
Interpretation Bias as a Mechanism of Treatment Response in OCD
Lead Sponsor:
Mclean Hospital
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I ...
Eligibility Criteria
Inclusion
- 1\) OCD Institute patients
- 2\) adults (\> 18 years old)
- 3\) able to complete a computer task for 20 minutes
- 4\) consent to main OCD Institute study protocol
- 5\) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
- 6\) score of \>131 on the Obsessive Beliefs Questionnaire-44 at admission \[which is 1 SD above the mean score of the non-clinical sample reported in the original validation paper by the Obsessive Compulsive Cognitions Working Group (2005)\]
Exclusion
- 1\) Currently experiencing acute symptoms of psychosis
- 2\) Psychotic disorder diagnosis
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05224414
Start Date
March 30 2022
End Date
August 31 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478